Home/Migra-Therapeutics/Lily Yang

LY

Lily Yang

President, Co-Founder

Migra-Therapeutics

Therapeutic Areas

Migra-Therapeutics Pipeline

Drug	Indication	Phase
MIGRA-NP01	Pancreatic Cancer	Preclinical
MIGRA-Cell Delivery Platform	Solid Tumors (Immunotherapy)	Research

Leadership Team at Migra-Therapeutics

Chief Operating Officer, Co-Founder

Research Scientist

View full Migra-Therapeutics profile